Literature DB >> 1638200

Drug management of ulcerative colitis.

M A Kamm1, A Senapati.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1638200      PMCID： PMC1882464          DOI： 10.1136/bmj.305.6844.35

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  31 in total

1.  Effects of topical 5-aminosalicylic acid and prednisolone on prostaglandin E2 and leukotriene B4 levels determined by equilibrium in vivo dialysis of rectum in relapsing ulcerative colitis.

Authors:  K Lauritsen; L S Laursen; K Bukhave; J Rask-Madsen
Journal:  Gastroenterology       Date:  1986-10       Impact factor: 22.682

2.  Controlled trial of bowel rest in the treatment of severe acute colitis.

Authors:  P B McIntyre; J Powell-Tuck; S R Wood; J E Lennard-Jones; E Lerebours; P Hecketsweiler; J P Galmiche; R Colin
Journal:  Gut       Date:  1986-05       Impact factor: 23.059

3.  Controlled trial of intravenous metronidazole as an adjunct to corticosteroids in severe ulcerative colitis.

Authors:  R W Chapman; W S Selby; D P Jewell
Journal:  Gut       Date:  1986-10       Impact factor: 23.059

4.  Role of platelet-activating factor in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine and prednisolone.

Authors:  R Eliakim; F Karmeli; E Razin; D Rachmilewitz
Journal:  Gastroenterology       Date:  1988-11       Impact factor: 22.682

5.  A controlled randomized trial of budesonide versus prednisolone retention enemas in active distal ulcerative colitis.

Authors:  A Danielsson; G Hellers; E Lyrenäs; R Löfberg; A Nilsson; O Olsson; S A Olsson; T Persson; L Salde; J Naesdal
Journal:  Scand J Gastroenterol       Date:  1987-10       Impact factor: 2.423

6.  Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study.

Authors:  K W Schroeder; W J Tremaine; D M Ilstrup
Journal:  N Engl J Med       Date:  1987-12-24       Impact factor: 91.245

7.  6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity.

Authors:  D H Present; S J Meltzer; M P Krumholz; A Wolke; B I Korelitz
Journal:  Ann Intern Med       Date:  1989-10-15       Impact factor: 25.391

8.  Therapeutic benefits from a poorly absorbed prednisolone enema in distal colitis.

Authors:  P B McIntyre; F A Macrae; L Berghouse; J English; J E Lennard-Jones
Journal:  Gut       Date:  1985-08       Impact factor: 23.059

9.  Azodisal sodium in the treatment of ulcerative colitis. A study of tolerance and relapse-prevention properties.

Authors:  H Sandberg-Gertzén; G Järnerot; W Kraaz
Journal:  Gastroenterology       Date:  1986-04       Impact factor: 22.682

10.  Azodisalicylate (azodisal sodium) causes intestinal secretion. Comparative study of the effect of azodisalicylate, sulfasalazine, 5-aminosalicylic acid and sulfapyridine on the water and electrolyte transfer and the morphology of the rat ileum and colon in vivo.

Authors:  K J Goerg; R Wanitschke; H Gabbert; J Breiling; M Franke; K H Meyer zum Büschenfelde
Journal:  Digestion       Date:  1987       Impact factor: 3.216
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.